Literature DB >> 16890289

Characterization of three distinct CpG oligonucleotide classes which differ in ability to induce IFN alpha/beta activity and cell proliferation in Atlantic salmon (Salmo salar L.) leukocytes.

Guro Strandskog1, Terje Ellingsen, Jorunn B Jørgensen.   

Abstract

Oligodeoxynucleotides (ODNs) containing unmethylated CpG dinucleotides within specific sequence contexts (CpG motifs) are in humans divided into three distinct classes (A, B and C). The CpG ODNs, like baterial DNA, are recognized by the vertebrate immune system and are known to stimulate immune responses. The characterization of the different classes is based on their structure and biological activity. In this study, we report the effects of these classes of CpG ODNs as they are defined in humans on IFN alpha/beta production and cell proliferation in Atlantic salmon spleen, head kidney and blood leukocytes. These studies revealed that CpG A together with CpG C are strong inducers of IFN alpha/beta in spleen and head kidney leukocytes, whilst CpG B and CpG C had the highest capacity to stimulate cell proliferation in all three cell populations. These findings are the first to establish that the effects of the different CpG classes are comparable between fish and man.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890289     DOI: 10.1016/j.dci.2006.05.004

Source DB:  PubMed          Journal:  Dev Comp Immunol        ISSN: 0145-305X            Impact factor:   3.636


  9 in total

1.  Unmethylated CpG oligodeoxynucleotides activate head kidney leukocytes of Atlantic cod, Gadus morhua.

Authors:  Christopher Marlowe A Caipang; Sanchala Gallage; Carlo C Lazado; Monica F Brinchmann; Viswanath Kiron
Journal:  Fish Physiol Biochem       Date:  2010-03-28       Impact factor: 2.794

Review 2.  Targeting Toll-like receptors: emerging therapeutics?

Authors:  Elizabeth J Hennessy; Andrew E Parker; Luke A J O'Neill
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

3.  MyD88 interacts with interferon regulatory factor (IRF) 3 and IRF7 in Atlantic salmon (Salmo salar): transgenic SsMyD88 modulates the IRF-induced type I interferon response and accumulates in aggresomes.

Authors:  Dimitar B Iliev; Mehrdad Sobhkhez; Kjersti Fremmerlid; Jorunn B Jørgensen
Journal:  J Biol Chem       Date:  2011-10-11       Impact factor: 5.157

4.  CpGs Induce Differentiation of Atlantic Salmon Mononuclear Phagocytes Into Cells With Dendritic Morphology and a Proinflammatory Transcriptional Profile but an Exhausted Allostimulatory Activity.

Authors:  Dimitar B Iliev; Leidy Lagos; Hanna L Thim; Sven M Jørgensen; Aleksei Krasnov; Jorunn B Jørgensen
Journal:  Front Immunol       Date:  2019-03-13       Impact factor: 7.561

Review 5.  Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.

Authors:  Chao-Yang Lai; Guann-Yi Yu; Yunping Luo; Rong Xiang; Tsung-Hsien Chuang
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

6.  Microbial Danger Signals Control Transcriptional Induction of Distinct MHC Class I L Lineage Genes in Atlantic Salmon.

Authors:  Steingrim Svenning; Agata T Gondek-Wyrozemska; Yorick Andreas van der Wal; Børre Robertsen; Ingvill Jensen; Jorunn B Jørgensen; Eva-Stina Edholm
Journal:  Front Immunol       Date:  2019-10-11       Impact factor: 7.561

7.  Dietary Immunostimulant CpG Modulates MicroRNA Biomarkers Associated with Immune Responses in Atlantic Salmon (Salmo salar).

Authors:  Xi Xue; Nardos Tesfaye Woldemariam; Albert Caballero-Solares; Navaneethaiyer Umasuthan; Mark D Fast; Richard G Taylor; Matthew L Rise; Rune Andreassen
Journal:  Cells       Date:  2019-12-07       Impact factor: 6.600

8.  CpG oligonucleotides bind TLR9 and RRM-containing proteins in Atlantic salmon (Salmo salar).

Authors:  Dimitar B Iliev; Ingrid Skjæveland; Jorunn B Jørgensen
Journal:  BMC Immunol       Date:  2013-03-01       Impact factor: 3.615

9.  Vaccine Adjuvants in Fish Vaccines Make a Difference: Comparing Three Adjuvants (Montanide ISA763A Oil, CpG/Poly I:C Combo and VHSV Glycoprotein) Alone or in Combination Formulated with an Inactivated Whole Salmonid Alphavirus Antigen.

Authors:  Hanna L Thim; Stéphane Villoing; Marian McLoughlin; Karen Elina Christie; Søren Grove; Petter Frost; Jorunn B Jørgensen
Journal:  Vaccines (Basel)       Date:  2014-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.